Chemed (NYSE:CHE) CEO Kevin Mcnamara Sells 2,000 Shares of Stock

Chemed Corporation (NYSE:CHE) CEO Kevin Mcnamara sold 2,000 shares of the business’s stock in a transaction dated Friday, September 18th. The shares were sold at an average price of $501.40, for a total value of $1,002,800.00. Following the completion of the transaction, the chief executive officer owned 68,418 shares in the company, valued at $34,304,785.20. This trade represents a 2.84% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Chemed Stock Performance

Chemed stock traded down $6.43 during mid-day trading on Monday, reaching $497.63. 32,582 shares of the company were exchanged, compared to its average volume of 209,088. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $557.00. The firm’s 50-day simple moving average is $523.01 and its two-hundred day simple moving average is $455.85. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91. The firm has a market cap of $6.50 billion, a PE ratio of 25.04, a price-to-earnings-growth ratio of 2.03 and a beta of 0.51.

Chemed (NYSE:CHE) last released its earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The business had revenue of $673.25 million for the quarter, compared to analyst estimates of $665.04 million. During the same quarter in the previous year, the company posted $4.27 earnings per share. The company’s revenue for the quarter was up 8.8% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Equities analysts predict that Chemed Corporation will post 23.55 earnings per share for the current fiscal year.

Chemed Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 3rd. Stockholders of record on Monday, August 17th were paid a $0.70 dividend. This is a boost from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date was Monday, August 17th. This represents a $2.80 annualized dividend and a dividend yield of 0.6%. Chemed’s dividend payout ratio (DPR) is 14.06%.

Analyst Ratings Changes

Several equities analysts have issued reports on CHE shares. Weiss Ratings upgraded Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Wall Street Zen cut shares of Chemed from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Royal Bank Of Canada boosted their target price on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research note on Thursday, July 30th. Bank of America reissued a “neutral” rating on shares of Chemed in a research note on Wednesday, July 29th. Finally, Oppenheimer increased their price objective on shares of Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a report on Friday, July 31st. One investment analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $530.75.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Sequoia Financial Advisors LLC purchased a new stake in Chemed during the 2nd quarter worth $563,000. Integrated Wealth Concepts LLC grew its position in shares of Chemed by 9.7% in the 2nd quarter. Integrated Wealth Concepts LLC now owns 27,774 shares of the company’s stock worth $12,936,000 after acquiring an additional 2,461 shares in the last quarter. NewEdge Advisors LLC boosted its holdings in Chemed by 4,167.3% in the second quarter. NewEdge Advisors LLC now owns 2,091 shares of the company’s stock worth $974,000 after purchasing an additional 2,042 shares during the period. Squarepoint Ops LLC boosted its stake in Chemed by 50.5% in the second quarter. Squarepoint Ops LLC now owns 5,201 shares of the company’s stock valued at $2,422,000 after acquiring an additional 1,745 shares during the period. Finally, Baird Financial Group Inc. boosted its position in Chemed by 28.8% during the 2nd quarter. Baird Financial Group Inc. now owns 1,874 shares of the company’s stock valued at $873,000 after purchasing an additional 419 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

About Chemed

Chemed Corporation is a diversified holding company that operates businesses in the healthcare and residential and commercial services industries. Its primary operations are conducted through VITAS Healthcare and Roto-Rooter.

VITAS Healthcare provides hospice and palliative care for patients with advanced illnesses. Its services are delivered in patients’ homes, hospice residences, nursing facilities, hospitals and other care settings, primarily throughout the United States. Care is provided by interdisciplinary teams that may include physicians, nurses, hospice aides, social workers and chaplains.

Roto-Rooter provides plumbing and drain-cleaning services, as well as water cleanup and related services for residential and commercial customers.